Cargando…

Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era

PURPOSE: The aim of this work is to review and synthesize the existing evidence and recommendations regarding to the therapeutic and surgical indications as well as monitoring of patients with Penile Cancer in COVID-19 era and to propose an action protocol to facilitate decision-making. MATERIAL AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Casco, Nelson Canales, Carmona, María Jiménez, Soto, Álvaro Juárez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Urologia 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719983/
https://www.ncbi.nlm.nih.gov/pubmed/32568497
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.S110
_version_ 1783619779333980160
author Casco, Nelson Canales
Carmona, María Jiménez
Soto, Álvaro Juárez
author_facet Casco, Nelson Canales
Carmona, María Jiménez
Soto, Álvaro Juárez
author_sort Casco, Nelson Canales
collection PubMed
description PURPOSE: The aim of this work is to review and synthesize the existing evidence and recommendations regarding to the therapeutic and surgical indications as well as monitoring of patients with Penile Cancer in COVID-19 era and to propose an action protocol to facilitate decision-making. MATERIAL AND METHODS: A non-systematic review of the literature regarding the management of penile cancer during the COVID-19 pandemic was performed until April 30, 2020. We propose our recommendations based on this evidence. RESULTS: Penile cancer is an uncommon but aggressive disease. Prognosis is determined by several characteristics, being the most important the presence of lymph nodes, in which case, treatment should not be delayed. For these reasons, an initial evaluation is mandatory. Priority classifications, based on the oncological outcomes when treatment is delayed, have been made in order to separate deferrable disease from the one that needs high priority treatment. In penile cancer with low risk of progression, surgical treatment can be delayed, but other options must be considered, like topical treatment or laser therapy. In cases with intermediate risk of progression, surgical treatment may be delayed up to three months, but we must consider radiation therapy and brachytherapy as effective options. When feasible, follow-up should by telemonitoring. CONCLUSIONS: In the COVID 19 era, initial evaluation of the patient is mandatory. Histological diagnosis with local staging is necessary before offering any therapeutic option. In case of superficial non-invasive disease, topical treatment is effective in absence of lymph node involvement. In selected patients, radiotherapy is an organpreserving approach with good results. Non-deferrable surgical treatment must be performed by an experienced surgeon and as an outpatient procedure when possible. When indicated, iLND should not be delayed since it is decisive for patient survival. Follow-up should be by telemonitoring.
format Online
Article
Text
id pubmed-7719983
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Sociedade Brasileira de Urologia
record_format MEDLINE/PubMed
spelling pubmed-77199832020-12-11 Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era Casco, Nelson Canales Carmona, María Jiménez Soto, Álvaro Juárez Int Braz J Urol Review Article PURPOSE: The aim of this work is to review and synthesize the existing evidence and recommendations regarding to the therapeutic and surgical indications as well as monitoring of patients with Penile Cancer in COVID-19 era and to propose an action protocol to facilitate decision-making. MATERIAL AND METHODS: A non-systematic review of the literature regarding the management of penile cancer during the COVID-19 pandemic was performed until April 30, 2020. We propose our recommendations based on this evidence. RESULTS: Penile cancer is an uncommon but aggressive disease. Prognosis is determined by several characteristics, being the most important the presence of lymph nodes, in which case, treatment should not be delayed. For these reasons, an initial evaluation is mandatory. Priority classifications, based on the oncological outcomes when treatment is delayed, have been made in order to separate deferrable disease from the one that needs high priority treatment. In penile cancer with low risk of progression, surgical treatment can be delayed, but other options must be considered, like topical treatment or laser therapy. In cases with intermediate risk of progression, surgical treatment may be delayed up to three months, but we must consider radiation therapy and brachytherapy as effective options. When feasible, follow-up should by telemonitoring. CONCLUSIONS: In the COVID 19 era, initial evaluation of the patient is mandatory. Histological diagnosis with local staging is necessary before offering any therapeutic option. In case of superficial non-invasive disease, topical treatment is effective in absence of lymph node involvement. In selected patients, radiotherapy is an organpreserving approach with good results. Non-deferrable surgical treatment must be performed by an experienced surgeon and as an outpatient procedure when possible. When indicated, iLND should not be delayed since it is decisive for patient survival. Follow-up should be by telemonitoring. Sociedade Brasileira de Urologia 2020-07-27 /pmc/articles/PMC7719983/ /pubmed/32568497 http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.S110 Text en https://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Casco, Nelson Canales
Carmona, María Jiménez
Soto, Álvaro Juárez
Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title_full Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title_fullStr Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title_full_unstemmed Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title_short Therapeutic and Surgical Indications for Patients with Penile Cancer in the COVID-19 era
title_sort therapeutic and surgical indications for patients with penile cancer in the covid-19 era
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7719983/
https://www.ncbi.nlm.nih.gov/pubmed/32568497
http://dx.doi.org/10.1590/S1677-5538.IBJU.2020.S110
work_keys_str_mv AT casconelsoncanales therapeuticandsurgicalindicationsforpatientswithpenilecancerinthecovid19era
AT carmonamariajimenez therapeuticandsurgicalindicationsforpatientswithpenilecancerinthecovid19era
AT sotoalvarojuarez therapeuticandsurgicalindicationsforpatientswithpenilecancerinthecovid19era